Altor BioScience, LLC

États‑Unis d’Amérique

 
Quantité totale PI 72
Rang # Quantité totale PI 18 615
Note d'activité PI 2,7/5.0    63
Rang # Activité PI 11 369
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

58 4
1 3
4 1
1
 
Dernier brevet 2025 - Il-15-based fusions to il-12 and...
Premier brevet 2002 - P53 binding t cell receptor mole...
Dernière marque 2023 - ANKTIVA
Première marque 2019 - ANKTIVA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Il-15-based fusions to il-12 and il-18. The invention features multi-specific fusion protein com...
Invention Senescence treatment with il-15-based fusions to il-7 and il-21. The invention features multi-sp...
Invention Il-15-based molecules and methods of use thereof. The invention features combination therapies u...
Invention Method for stimulating tumor-infiltrating lymphocytes with an il-15:il-15r complex. The inventio...
Invention Compositions comprising il-15n72d-based molecules and bacillus calmette-guerin (bcg). The invent...
2023 Invention Methods of treating a neoplasia with il-15-based molecules and ctla-4 antibody. The invention fea...
Invention Il-15-based fusions to il-12 and il-18. The invention features multi-specific fusion protein comp...
Invention Multimeric il-15 soluble fusion molecules and methods of making and using same. The present inve...
Invention Il-15-based fusions to il-7 and il-21. The invention features multi-specific fusion protein comp...
Invention Fusion molecules and il-15 variants. The instant invention provides soluble fusion protein comple...
P/S Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases,...
P/S Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, ...
Invention Il-15-based molecules and methods of treating a neoplasia. The invention features combination the...
Invention Method for treating neoplasia with an anti-cd38 antibody and an il-15:il-15r complex. The inventi...
P/S Medical research and product development; pharmaceutical research and development services; medic...
P/S Medical services; medical information; providing a website featuring medical information in the f...
2022 Invention Method of treating cancer with composition comprising il-15-based molecules and bcg. The inventio...
Invention Compositions comprising il-15-based molecules and immune checkpoint inhibitor antibodies. The inv...
P/S Pharmaceutical preparations and substances for the treatment of human diseases and animal disease...
Invention Il-15-based molecules and methods of use thereof. The invention features combination therapies us...
P/S Pharmaceutical preparations for the prevention and treatment of cancer;
2021 Invention Il-15-based fusions to il-7 and il-21. The invention features multi-specific fusion protein compl...
Invention Multimeric il-15 soluble fusion molecules and methods of making and using same. The present inven...
Invention Multimeric il-15-based molecules. The invention features multi-specific protein complexes with on...
2020 Invention Il-15 fusion protein enhanced adoptive cell therapeutics. Combination therapies which include nat...
Invention Human immunodeficiency virus-specific t cell receptors. Engineered TCR molecules specific to ret...
Invention Human immunodeficiency virus-specific t cell receptors. Engineered TCR molecules specific to retr...
2019 Invention Interleukin 15 (il-15) variants. The instant invention provides soluble fusion protein complexes ...
P/S Pharmaceutical preparations for the prevention and treatment of cancer
P/S Pharmaceutical preparations for the prevention and treatment of cancer.
Invention Compositions comprising il-2 fusion proteins and methods for treating neoplasia. The invention p...
Invention T cell receptor fusions and conjugates and methods of use thereof. Featured is T cell receptor c...
Invention Superkine. Contemplated compositions and methods comprise chimeric molecule complexes that advant...
P/S Pharmaceutical preparations for the prevention and treatment of cancer
Invention Anti-pdl1, il-15 and tgf-beta receptor combination molecules. The invention features multi-specif...
Invention Anti-pdl1, il-15 and tgf-beta receptor combination molecules. The invention features multi- speci...
2018 Invention Method of treating neoplasia with a multimeric il-15 soluble fusion molecule. The present inventi...
2017 Invention Hiv vpr-specific t-cell receptors. The instant invention provides TCRs having one or more amino a...
Invention Construction and characterization of multimeric il-15-based molecules with cd3 binding domains. T...